Rice Hall James & Associates, LLC Harmony Biosciences Holdings, Inc. Transaction History

Rice Hall James & Associates, LLC

$1.69 Billion
Q3 2024

A detailed history of Rice Hall James & Associates, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 79,271 shares of HRMY stock, worth $2.7 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

79,271

Previous 80,512 1.54%

Holding current value

$2.7 Million

Previous $2.43 Million 30.34%

% of portfolio

0.19%

Previous 0.16%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$30.0 - $39.95 $37,230 - $49,577	-1,241 Reduced 1.54%	79,271 $3.17 Million
Q2 2024 Aug 07, 2024	BUY	$28.81 - $33.01 $687,608 - $787,849	23,867 Added 42.13%	80,512 $2.43 Million
Q1 2024 Apr 23, 2024	SELL	$29.93 - $35.06 $320,520 - $375,457	-10,709 Reduced 15.9%	56,645 $1.9 Million
Q4 2023 Feb 08, 2024	SELL	$19.2 - $33.78 $647,808 - $1.14 Million	-33,740 Reduced 33.37%	67,354 $2.18 Million
Q3 2023 Nov 02, 2023	SELL	$31.89 - $39.03 $46,431 - $56,827	-1,456 Reduced 1.42%	101,094 $3.31 Million
Q2 2023 Jul 24, 2023	SELL	$30.5 - $37.4 $547,231 - $671,030	-17,942 Reduced 14.89%	102,550 $3.61 Million
Q1 2023 May 11, 2023	BUY	$30.8 - $53.92 $1.18 Million - $2.06 Million	38,174 Added 46.37%	120,492 $3.93 Million
Q4 2022 Jan 27, 2023	SELL	$45.4 - $60.91 $1.08 Million - $1.45 Million	-23,809 Reduced 22.43%	82,318 $0
Q3 2022 Nov 01, 2022	SELL	$42.06 - $55.45 $59,346 - $78,239	-1,411 Reduced 1.31%	106,127 $4.7 Million
Q2 2022 Aug 08, 2022	SELL	$33.54 - $52.15 $541,469 - $841,909	-16,144 Reduced 13.05%	107,538 $5.25 Million
Q1 2022 May 05, 2022	SELL	$33.14 - $51.13 $462,766 - $713,979	-13,964 Reduced 10.14%	123,682 $6.02 Million
Q4 2021 Feb 14, 2022	SELL	$34.09 - $43.91 $53,453 - $68,850	-1,568 Reduced 1.13%	137,646 $5.87 Million
Q3 2021 Nov 09, 2021	SELL	$25.68 - $38.61 $31,432 - $47,258	-1,224 Reduced 0.87%	139,214 $5.34 Million
Q2 2021 Jul 29, 2021	SELL	$25.96 - $33.44 $167,883 - $216,256	-6,467 Reduced 4.4%	140,438 $3.97 Million
Q1 2021 May 14, 2021	BUY	$27.56 - $40.37 $3.1 Million - $4.55 Million	112,630 Added 328.61%	146,905 $4.85 Million
Q4 2020 Feb 16, 2021	BUY	$31.74 - $51.34 $1.09 Million - $1.76 Million	34,275 New	34,275 $1.24 Million

Others Institutions Holding HRMY

# of Institutions

242

Shares Held

45.1M

Call Options Held

108K

Put Options Held

49.2K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.02B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.

Account

Rice Hall James & Associates, LLC Harmony Biosciences Holdings, Inc. Transaction History